Validation of inhibitors of an ABC transporter required to transport lipopolysaccharide to the cell surface in Escherichia coli

被引:36
作者
Sherman, David J. [1 ]
Okuda, Suguru [1 ]
Denny, William A. [2 ]
Kahne, Daniel [1 ,3 ]
机构
[1] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA
[2] Univ Auckland, Sch Med Sci, Auckland Canc Soc Res Ctr, Auckland 1020, New Zealand
[3] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Gram-negative; Lipopolysaccharide; Antibiotics; ABC transporter; BACTERIAL OUTER-MEMBRANE; CHK1 CHECKPOINT KINASES; PEPTIDOMIMETIC ANTIBIOTICS; PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; MULTIDRUG-RESISTANCE; ENVELOPE BIOGENESIS; PROTEIN COMPLEX; IDENTIFICATION; WEE1;
D O I
10.1016/j.bmc.2013.04.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The presence of lipopolysaccharide (LPS) in the outer leaflet of the outer membrane (OM) of Gram-negative bacteria creates a permeability barrier that prevents the entry of most currently available antibiotics. The seven lipopolysaccharide transport (Lpt) proteins involved in transporting and assembling this glycolipid are essential for growth and division in Escherichia coli; therefore, inhibiting their functions leads to cell death. LptB, the ATPase that provides energy for LPS transport and assembly, forms a complex with three other inner membrane (IM) components, LptC, F, and G. We demonstrate that inhibitors of pure LptB can also inhibit the full IM complex, LptBFGC, purified in detergent. We also compare inhibition of LptB and the LptBFGC complex with the antibiotic activity of these compounds. Our long-term goal is to develop tools to study inhibitors of LPS biogenesis that could serve as potentiators by disrupting the OM permeability barrier, facilitating entry of clinically used antibiotics not normally used to treat Gram-negative infections, or that can serve as antibiotics themselves. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4846 / 4851
页数:6
相关论文
共 44 条
[1]  
Barb AW, 2008, CURR PHARM BIOTECHNO, V9, P9
[2]   Biogenesis of the gram-negative bacterial outer membrane [J].
Bos, Martine P. ;
Robert, Viviane ;
Tommassen, Jan .
ANNUAL REVIEW OF MICROBIOLOGY, 2007, 61 :191-214
[3]   Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface [J].
Bos, MP ;
Tefsen, B ;
Geurtsen, J ;
Tommassen, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (25) :9417-9422
[4]   Imp/OstA is required for cell envelope biogenesis in Escherichia coli [J].
Braun, M ;
Silhavy, TJ .
MOLECULAR MICROBIOLOGY, 2002, 45 (05) :1289-1302
[5]   ATPases as drug targets:: Learning from their structure [J].
Chène, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (09) :665-673
[6]   A METHOD FOR THE DETERMINATION OF INORGANIC-PHOSPHATE IN THE PRESENCE OF LABILE ORGANIC PHOSPHATE AND HIGH-CONCENTRATIONS OF PROTEIN - APPLICATION TO LENS ATPASES [J].
CHIFFLET, S ;
TORRIGLIA, A ;
CHIESA, R ;
TOLOSA, S .
ANALYTICAL BIOCHEMISTRY, 1988, 168 (01) :1-4
[7]   Proteins Required for Lipopolysaccharide Assembly in Escherichia coli Form a Transenvelope Complex [J].
Chng, Shu-Sin ;
Gronenberg, Luisa S. ;
Kahne, Daniel .
BIOCHEMISTRY, 2010, 49 (22) :4565-4567
[8]   The ABC of ABCs: a phylogenetic and functional classification of ABC systems in living organisms [J].
Dassa, E ;
Bouige, P .
RESEARCH IN MICROBIOLOGY, 2001, 152 (3-4) :211-229
[9]   Structure, function, and evolution of bacterial ATP-binding cassette systems [J].
Davidson, Amy L. ;
Dassa, Elie ;
Orelle, Cedric ;
Chen, Jue .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2008, 72 (02) :317-364
[10]   Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin [J].
Eggert, US ;
Ruiz, N ;
Falcone, BV ;
Branstrom, AA ;
Goldman, RC ;
Silhavy, TJ ;
Kahne, D .
SCIENCE, 2001, 294 (5541) :361-364